EE03832B1 - Heptapeptiidanaloogid - Google Patents

Heptapeptiidanaloogid

Info

Publication number: EE03832B1
Authority: EE; Estonia
Prior art keywords: heptapeptide analogs; heptapeptide; analogs
Prior art date: 1996-11-26

Application number

EEP199900210A

Other languages

English (en)

Estonian (et)

Other versions

EE9900210A (et

Inventor

Melin Per

Nilsson Anders

A. Trojnar Jerzy

Aurell Carl-Johan

Riviere Pierre

Haigh Robert

Original Assignee

Ferring B.V.

Ferring Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-26

Filing date

1997-11-21

Publication date

2002-08-15

1997-11-21 Application filed by Ferring B.V., Ferring Ab filed Critical Ferring B.V.

1999-12-15 Publication of EE9900210A publication Critical patent/EE9900210A/xx

2002-08-15 Publication of EE03832B1 publication Critical patent/EE03832B1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Neurology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Pregnancy & Childbirth (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EEP199900210A 1996-11-26 1997-11-21 Heptapeptiidanaloogid EE03832B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604341A SE9604341D0 (sv)	1996-11-26	1996-11-26	Hepta-peptide oxytocin analogue
PCT/SE1997/001968 WO1998023636A1 (fr)	1996-11-26	1997-11-21	Analogues d'heptapeptide oxytocine

Publications (2)

Publication Number	Publication Date
EE9900210A EE9900210A (et)	1999-12-15
EE03832B1 true EE03832B1 (et)	2002-08-15

Family

ID=20404757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900210A EE03832B1 (et)	1996-11-26	1997-11-21	Heptapeptiidanaloogid

Country Status (34)

Country	Link
US (1)	US6143722A (fr)
EP (1)	EP0938496B1 (fr)
JP (1)	JP3405460B2 (fr)
KR (1)	KR100463132B1 (fr)
CN (1)	CN1129606C (fr)
AR (1)	AR008531A1 (fr)
AT (1)	ATE242264T1 (fr)
AU (1)	AU713424B2 (fr)
BR (1)	BR9713366B1 (fr)
CA (1)	CA2272990C (fr)
CZ (1)	CZ299532B6 (fr)
DE (1)	DE69722651T2 (fr)
DK (1)	DK0938496T3 (fr)
EE (1)	EE03832B1 (fr)
ES (1)	ES2203823T3 (fr)
HR (1)	HRP970630B1 (fr)
HU (1)	HU228568B1 (fr)
IL (1)	IL129519A (fr)
LT (1)	LT4650B (fr)
LV (1)	LV12350B (fr)
MY (1)	MY125555A (fr)
NO (1)	NO321380B1 (fr)
NZ (1)	NZ336445A (fr)
PL (1)	PL189292B1 (fr)
PT (1)	PT938496E (fr)
RO (1)	RO120772B1 (fr)
RU (1)	RU2180668C2 (fr)
SE (1)	SE9604341D0 (fr)
SI (1)	SI20026B (fr)
SK (1)	SK283800B6 (fr)
TR (1)	TR199901028T2 (fr)
UA (1)	UA54459C2 (fr)
WO (1)	WO1998023636A1 (fr)
ZA (1)	ZA9710518B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2181297C2 (ru) *	2000-06-20	2002-04-20	Эпштейн Олег Ильич	Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) *	2000-11-21	2002-11-05	Arthur Vanmoor	Method of treating menstrual pain by enhancing the effectiveness of the human immune system
AU2003211011A1 (en) *	2002-02-27	2003-09-09	Ferring Bv	Intermediates and methods for making heptapeptide oxytocin analogues
WO2003093816A2 (fr) *	2002-05-02	2003-11-13	Bayer Healtchare Ag	Diagnostics et therapeutiques pour lutter contre des maladies associees au recepteur de l'oxytocine (oxtr)
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
UA76639C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
ATE301990T1 (de) *	2003-07-25	2005-09-15	Ferring Bv	Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
DE60305043T2 (de) *	2003-11-13	2006-11-30	Ferring B.V.	Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
EP1555029A1 (fr)	2004-01-19	2005-07-20	Ferring B.V.	Utilisation de substances à activité oxytocique pour la préparation de médicaments destinés au traitement de l'hypertension
US20060171909A1 (en) *	2005-02-03	2006-08-03	The Procter & Gamble Company	Cosmetic compositions comprising colorants with low free dye
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
KR20140143461A (ko)	2007-08-06	2014-12-16	알레간 인코포레이티드	데스모프레신 약물 전달을 위한 방법 및 장치
HRP20140716T1 (hr) *	2008-03-31	2014-08-29	Ferring B.V.	Analozi oksitocina
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
ES2756706T3 (es)	2008-05-21	2020-04-27	Ferring Bv	Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
TWI463990B (zh) *	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
KR20140014059A (ko)	2010-07-15	2014-02-05	올레그 일리치 엡쉬테인	활성화되고 강화된 형태의 항체의 효과를 증가시키는 방법
JO3400B1 (ar) *	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
US9376467B2 (en)	2011-03-09	2016-06-28	Jitsubo Co., Ltd.	Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN102875650B (zh) *	2012-09-26	2014-06-11	深圳翰宇药业股份有限公司	巴卢西班的制备方法
US9365615B2 (en)	2013-09-09	2016-06-14	Jitsubo Co., Ltd.	Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
ES2716862T3 (es)	2014-12-22	2019-06-17	Ferring Bv	Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
US9925233B2 (en)	2015-01-30	2018-03-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en)	2015-01-30	2017-09-05	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en)	2015-01-30	2017-08-29	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en)	2015-01-30	2017-06-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en)	2015-01-30	2017-08-29	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en)	2015-01-30	2018-04-10	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
EP3359557A1 (fr)	2015-10-06	2018-08-15	Ferring B.V.	Nouveaux procédés de fabrication de barusiban et ses intermédiaires
LT3400217T (lt)	2016-01-04	2022-06-27	Merck Serono S.A.	Hidroksipropiltiazolidino karboksamido l-valinato darinys, jo druska ir jo kristalinė forma
WO2018015497A2 (fr)	2016-07-21	2018-01-25	ObsEva S.A.	Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
AU2020340670A1 (en)	2019-09-03	2022-04-07	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2021160597A1 (fr)	2020-02-10	2021-08-19	ObsEva S.A.	Biomarqueurs pour une thérapie par antagoniste du récepteur de l'oxytocine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT89279B (pt) *	1987-12-21	1993-08-31	Sandoz Sa	Processo para a preparacao de uma nova forma cristalina de ciclosporinas e de composicoes farmaceuticas que as contem
US5373089A (en) *	1988-09-02	1994-12-13	Northwestern University	Oxytocin antagonist
CA2036973A1 (fr) *	1990-02-27	1991-08-28	Mark G. Bock	Antagonistes de l'oxytocine, a base d'hexapeptide cyclique
SE9002384D0 (sv) *	1990-07-09	1990-07-09	Ferring Ab	Derivat av baklobshormoner
DE4022247A1 (de) *	1990-07-12	1992-01-16	Hoechst Ag	Verfahren zur extraktiven abtrennung von 2-alkylthio-5-phenylpyrimidinen aus ihren reaktionsgemischen
SE501678C2 (sv) *	1993-07-13	1995-04-10	Ferring Bv	Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv)	1994-01-27	2004-05-18	Per-Ingvar Nilsson	Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv)	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
SE9500249L (sv)	1995-01-25	1996-03-25	Valeo Engine Cooling Ab	Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

1996
- 1996-11-26 SE SE9604341A patent/SE9604341D0/xx unknown
1997
- 1997-11-21 EE EEP199900210A patent/EE03832B1/xx unknown
- 1997-11-21 CA CA002272990A patent/CA2272990C/fr not_active Expired - Lifetime
- 1997-11-21 EP EP97946210A patent/EP0938496B1/fr not_active Expired - Lifetime
- 1997-11-21 RO RO99-00593A patent/RO120772B1/ro unknown
- 1997-11-21 DE DE69722651T patent/DE69722651T2/de not_active Expired - Lifetime
- 1997-11-21 JP JP52460298A patent/JP3405460B2/ja not_active Expired - Lifetime
- 1997-11-21 NZ NZ336445A patent/NZ336445A/en not_active IP Right Cessation
- 1997-11-21 ES ES97946210T patent/ES2203823T3/es not_active Expired - Lifetime
- 1997-11-21 BR BRPI9713366-3A patent/BR9713366B1/pt not_active IP Right Cessation
- 1997-11-21 AU AU51429/98A patent/AU713424B2/en not_active Expired
- 1997-11-21 ZA ZA9710518A patent/ZA9710518B/xx unknown
- 1997-11-21 HU HU0000577A patent/HU228568B1/hu unknown
- 1997-11-21 IL IL12951997A patent/IL129519A/en not_active IP Right Cessation
- 1997-11-21 SK SK704-99A patent/SK283800B6/sk not_active IP Right Cessation
- 1997-11-21 CN CN97180014A patent/CN1129606C/zh not_active Expired - Fee Related
- 1997-11-21 PL PL97333876A patent/PL189292B1/pl unknown
- 1997-11-21 KR KR10-1999-7004449A patent/KR100463132B1/ko not_active Expired - Lifetime
- 1997-11-21 SI SI9720076A patent/SI20026B/sl unknown
- 1997-11-21 TR TR1999/01028T patent/TR199901028T2/xx unknown
- 1997-11-21 CZ CZ0183299A patent/CZ299532B6/cs not_active IP Right Cessation
- 1997-11-21 DK DK97946210T patent/DK0938496T3/da active
- 1997-11-21 WO PCT/SE1997/001968 patent/WO1998023636A1/fr not_active Ceased
- 1997-11-21 US US09/308,912 patent/US6143722A/en not_active Expired - Lifetime
- 1997-11-21 HR HR970630A patent/HRP970630B1/xx not_active IP Right Cessation
- 1997-11-21 UA UA99042410A patent/UA54459C2/uk unknown
- 1997-11-21 AT AT97946210T patent/ATE242264T1/de active
- 1997-11-21 PT PT97946210T patent/PT938496E/pt unknown
- 1997-11-21 RU RU99113364/04A patent/RU2180668C2/ru active
- 1997-11-25 MY MYPI97005691A patent/MY125555A/en unknown
- 1997-11-26 AR ARP970105543A patent/AR008531A1/es active IP Right Grant
1999
- 1999-04-30 LV LVP-99-77A patent/LV12350B/en unknown
- 1999-05-11 LT LT99-052A patent/LT4650B/lt not_active IP Right Cessation
- 1999-05-26 NO NO19992532A patent/NO321380B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL129519A (en)	2004-09-27
BR9713366A (pt)	2000-01-25
LV12350B (en)	1999-11-20
CZ183299A3 (cs)	2000-05-17
DK0938496T3 (da)	2003-10-06
HUP0000577A3 (en)	2001-02-28
JP3405460B2 (ja)	2003-05-12
AU713424B2 (en)	1999-12-02
CA2272990A1 (fr)	1998-06-04
DE69722651D1 (en)	2003-07-10
LV12350A (lv)	1999-09-20
ES2203823T3 (es)	2004-04-16
CZ299532B6 (cs)	2008-08-27
CA2272990C (fr)	2002-11-19
ATE242264T1 (de)	2003-06-15
AU5142998A (en)	1998-06-22
KR20000069045A (ko)	2000-11-25
UA54459C2 (uk)	2003-03-17
ZA9710518B (en)	1998-06-10
TR199901028T2 (xx)	1999-07-21
PL189292B1 (pl)	2005-07-29
MY125555A (en)	2006-08-30
SK283800B6 (sk)	2004-02-03
NO992532D0 (no)	1999-05-26
DE69722651T2 (de)	2004-04-08
NO321380B1 (no)	2006-05-02
US6143722A (en)	2000-11-07
HUP0000577A2 (hu)	2000-11-28
LT99052A (en)	2000-01-25
EP0938496A1 (fr)	1999-09-01
EE9900210A (et)	1999-12-15
HK1022481A1 (en)	2000-08-11
KR100463132B1 (ko)	2004-12-23
HRP970630B1 (en)	2002-04-30
LT4650B (lt)	2000-04-25
HRP970630A2 (en)	1998-10-31
BR9713366B1 (pt)	2010-05-18
PT938496E (pt)	2003-10-31
EP0938496B1 (fr)	2003-06-04
SK70499A3 (en)	2000-10-09
CN1238781A (zh)	1999-12-15
SI20026A (sl)	2000-02-29
JP2000507617A (ja)	2000-06-20
RO120772B1 (ro)	2006-07-28
RU2180668C2 (ru)	2002-03-20
CN1129606C (zh)	2003-12-03
HU228568B1 (en)	2013-04-29
WO1998023636A1 (fr)	1998-06-04
SI20026B (sl)	2000-06-30
IL129519A0 (en)	2000-02-29
NO992532L (no)	1999-05-26
NZ336445A (en)	2000-06-23
SE9604341D0 (sv)	1996-11-26
AR008531A1 (es)	2000-01-19

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
EE03832B1 (et)	2002-08-15	Heptapeptiidanaloogid
ID19609A (id)	1998-07-23	Senyawa-senyawa heterosiklik
ID18090A (id)	1998-02-26	Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
ID15904A (id)	1997-08-14	Senyawa-senyawa tiofenopirimidina
ID19476A (id)	1998-07-16	Senyawa piridilpirol
ID19474A (id)	1998-07-16	Turunan tiazola
NO985680D0 (no)	1998-12-04	Peptidderivater
DE69716924D1 (de)	2002-12-12	Phosphonat-nukleotid-verbindungen
ID18095A (id)	1998-02-26	Turunan tetrahidrokinolin
EP0996458A4 (fr)	2001-05-02	Analogues de sandramycine
BR9705635A (pt)	1999-05-18	Compostos
NO983849L (no)	1998-10-21	Peptidderivater
FI963194L (fi)	1996-09-23	Syklinen tulehduksenvastainen heptapeptidi
DK0923594T3 (da)	2003-02-10	Bromotiacumicinforbindelser
NO974125D0 (no)	1997-09-08	N-benzylazoliumderivater
DE69709659D1 (de)	2002-02-21	Halopropargyl-einschlussverbindungen
ID17945A (id)	1998-02-12	Lemari es
NO983506D0 (no)	1998-07-30	Mellomkobling
KR970007831U (ko)	1997-03-27	김밥 말이용 김발
FI965275A0 (fi)	1996-12-31	Aonglaoda i kartong- eller pappersmaskin
KR970056542U (ko)	1997-11-10	넥타이
FI3003U1 (fi)	1997-08-13	Kuormapankka
FI2674U1 (fi)	1996-12-19	Långnyppress i en pappers- eller kartongmaskin
FI964007A0 (fi)	1996-10-04	Styrsystem foer ventiler i en foerbraenningsmotor
FI963104A0 (fi)	1996-08-06	Basskontroll i en hemteateranordning